B. Metzler seel. Sohn & Co’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.57M | Hold |
12,482
| – | – | 0.02% | 435 |
|
|
2025
Q1 | $1.71M | Buy |
12,482
+2,354
| +23% | +$322K | 0.02% | 389 |
|
|
2024
Q4 | $1.55M | Buy |
10,128
+2,767
| +38% | +$423K | 0.02% | 438 |
|
|
2024
Q3 | $1.43M | Buy |
7,361
+1,500
| +26% | +$291K | 0.01% | 467 |
|
|
2024
Q2 | $1.36M | Buy |
5,861
+141
| +2% | +$32.7K | 0.01% | 459 |
|
|
2024
Q1 | $1.23M | Sell |
5,720
-729
| -11% | -$157K | 0.01% | 478 |
|
|
2023
Q4 | $1.67M | Sell |
6,449
-2,199
| -25% | -$569K | 0.02% | 400 |
|
|
2023
Q3 | $2.22M | Buy |
8,648
+1,960
| +29% | +$504K | 0.03% | 301 |
|
|
2023
Q2 | $1.91M | Buy |
6,688
+38
| +0.6% | +$10.8K | 0.03% | 382 |
|
|
2023
Q1 | $1.85M | Sell |
6,650
-1,086
| -14% | -$302K | 0.03% | 325 |
|
|
2022
Q4 | $2.14M | Buy |
7,736
+797
| +11% | +$221K | 0.04% | 276 |
|
|
2022
Q3 | $1.85M | Sell |
6,939
-3,709
| -35% | -$990K | 0.03% | 304 |
|
|
2022
Q2 | $2.17M | Sell |
10,648
-131
| -1% | -$26.7K | 0.04% | 275 |
|
|
2022
Q1 | $2.27M | Buy |
10,779
+584
| +6% | +$123K | 0.03% | 309 |
|
|
2021
Q4 | $2.45M | Buy |
10,195
+841
| +9% | +$202K | 0.03% | 291 |
|
|
2021
Q3 | $2.65M | Sell |
9,354
-1,526
| -14% | -$432K | 0.04% | 258 |
|
|
2021
Q2 | $3.77M | Sell |
10,880
-5,193
| -32% | -$1.8M | 0.06% | 192 |
|
|
2021
Q1 | $4.5M | Sell |
16,073
-1,760
| -10% | -$492K | 0.07% | 161 |
|
|
2020
Q4 | $4.51M | Buy |
+17,833
| New | +$4.51M | 0.08% | 146 |
|